Urogen Pharma Ltd (URGN)

Stock-Based Compensation

$16.12M

TTM · Period ending: · USD

URGN logo

URGN Stock-Based Compensation

Latest reported$16.12M
URGN TTM Stock-Based Comp ($1.97M → $16.12M)
High-resolution chart · PNG

URGN stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Urogen Pharma Ltd Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
16,115,000
13,517,000
11,959,000
12,132,000
12,594,000
13,421,000
13,108,000
12,416,000
11,151,000
9,813,000
9,343,000
9,100,000
6,876,000
7,477,000
8,140,000
11,129,000
16,644,000
19,867,000
23,113,000
24,282,000
25,530,000
26,603,000
28,025,000
29,564,000
30,044,000
30,137,000
29,967,000
30,779,000
33,051,000
33,548,000
30,642,000
24,034,000
16,677,000
10,544,000
6,300,000
4,612,000
2,967,000
1,824,000
1,967,000
1,575,000
1,124,000
782,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.